Skip to main content

Advertisement

SpringerLink
Log in

Is there a therapeutic window with some antidepressants for analgesic response?

  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

Most antidepressants and anticonvulsants used in chronic pain syndromes have dose- and concentration-response curves developed for their application to treat psychiatric disorders. Because these are important clinical tools in medication management of psychiatric syndromes, it is reasonable to expect that utilizing concentration-effect relationships and known sources of pharmacokinetic variability for determining doses for analgesia may also improve treatment tolerability and outcomes. Efforts to identify dosing “therapeutic windows” or minimum “thresholds” for analgesic efficacy have provided useful guidance for initiating treatment, reducing toxicity, and assisting with decision making in the face of limited therapeutic response. This article reviews the strengths, limitations, and potential of therapeutic drug monitoring of antidepressants and anticonvulsants as analgesics for selected chronic pain syndromes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Watson CP, Evans RJ, Reed K, et al.: Amitriptyline versus placebo in postherpetic neuralgia. Neurology 1982, 32:671–673.

    PubMed  CAS  Google Scholar 

  2. Max MB: Antidepressants as analgesics. In Pharmacological Approaches to the Treatment of Chronic Pain: New Concepts and Critical Issues (Progress in Pain Research and Management), vol 1. Edited by Fields HL, Liebeskind JC. Seattle: IASP Press; 1994:229–246.

    Google Scholar 

  3. McQuay HJ, Derry S, Moore RA, et al.: Enriched enrolment with randomised withdrawal (EERW): time for a new look at clinical trial design in chronic pain. Pain 2008, 135:217–220.

    Article  PubMed  Google Scholar 

  4. Max MB, Lynch SA, Muir J, et al.: Effects of desipramine, amitriptyline and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992, 326:1250–1256.

    PubMed  CAS  Google Scholar 

  5. Ohayon MM, Schatzberg AF: Using chronic pain to predict depressive morbidity in the general population. Arch Gen Psychiatry 2003, 60:39–47.

    Article  PubMed  Google Scholar 

  6. Bair MJ, Robinson RL, Eckert GJ, et al.: Impact of pain on depression treatment response in primary care. Psychosom Med 2004, 66:17–22.

    Article  PubMed  Google Scholar 

  7. Ward NG, Bloom BL, Friedel RO: The effectiveness of tricyclic antidepressants in the treatment of co-existing pain and depression. Pain 1979, 7:331–341.

    Article  PubMed  CAS  Google Scholar 

  8. Ward NG, Bokan JA, Phillips M, et al.: Antidepressants in concomitant chronic back pain and depression: doxepin and desipramine compared. J Clin Psychiatry 1984, 45:54–59.

    PubMed  CAS  Google Scholar 

  9. Brannan SK, Mallinckrodt CH, Brown EB, et al.: Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder. J Psychiatr Res 2005, 39:43–53.

    Article  PubMed  Google Scholar 

  10. Teter CJ, Kando JC, Wells BG, et al.: Depressive disorders. In Pharmacotherapy: A Pathophysiologic Approach, edn 7. Edited by Dipiro JT. New York: McGraw Hill; 2009:1123–1140.

    Google Scholar 

  11. Sindrup SH, Gram LF, Skjold T, et al.: Concentration-response relationship in imipramine treatment of diabetic neuropathy symptoms. Clin Pharmacol Ther 1990, 47:509–515.

    PubMed  CAS  Google Scholar 

  12. McQuay HJ, Carrol D, Glynn CJ: Dose-response for analgesic effect of amitriptyline in chronic pain. Anaesthesia 1993, 48:281–285.

    Article  PubMed  CAS  Google Scholar 

  13. Goodnick PJ: Pharmacokinetics of second generation antidepressants: fluoxetine. Psychopharmacol Bull 1991, 27:503–512.

    PubMed  CAS  Google Scholar 

  14. Atkinson JH, Slater MA, Williams RA, et al.: A placebo-controlled randomized clinical trial of nortriptyline for chronic low back pain. Pain 1998, 76:287–296.

    Article  PubMed  CAS  Google Scholar 

  15. Atkinson, JH, Slater MA, Wahlgren DR, et al.: Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity. Pain 1999, 83:137–145.

    Article  PubMed  CAS  Google Scholar 

  16. Max MB, Culnane M, Schafer SC, et al.: Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 1987, 37:589–596.

    PubMed  CAS  Google Scholar 

  17. Max MB, Culnane M, Schafer SC, et al.: Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology 1988, 38:1427–1432.

    PubMed  CAS  Google Scholar 

  18. Rasmussen PV, Jensen TS, Sindrup SH, et al.: TDM-based imipramine treatment in neuropathic pain. Ther Drug Monit 2004, 26:352–360.

    Article  PubMed  CAS  Google Scholar 

  19. Armstrong DG, Chappell AS, Le TK, et al.: Duloxetine for the management of diabetic peripheral neuropathic pain: evaluation of functional outcomes. Pain Med 2007, 8:410–418.

    Article  PubMed  Google Scholar 

  20. Arnold LM, Rosen A, Pritchett YL, et al.: A randomized, double blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain 2005, 119:5–15.

    Article  PubMed  CAS  Google Scholar 

  21. Pritchett YL, McCarberg BH, Watkin JG, et al.: Duloxetine for the management of diabetic peripheral neuropathic pain: response profile. Pain Med 2007, 8:397–409.

    Article  PubMed  Google Scholar 

  22. Kajdasz DK, Iyengar S, Desaiah D, et al.: Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies. Clin Ther 2007, 29:2536–2546.

    Article  PubMed  CAS  Google Scholar 

  23. Rowbotham MC, Goli V, Kunz NR, et al.: Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double blind study. Pain 2004, 110:697–706.

    Article  PubMed  CAS  Google Scholar 

  24. Sindrup SH, Bach FW, Madsen C, et al.: Venlafaxine versus imipramine in painful polyneuropathy: a randomized trial. Neurology 2003, 60:1284–1289.

    PubMed  CAS  Google Scholar 

  25. Kvinesdal B, Molin J, Froland A, et al.: Imipramine treatment of painful diabetic neuropathy. JAMA 1984, 251:1727–1730.

    Article  PubMed  CAS  Google Scholar 

  26. Max MB, Kishore-Kumar R, Schafer SC, et al.: Efficacy of desipramine in painful diabetic neuropathy: a placebo controlled trial. Pain 1991, 45:3–9.

    Article  PubMed  CAS  Google Scholar 

  27. Atkinson JH, Slater MA, Capparelli EV, et al.: Efficacy of noradrenergic and serotonergic antidepressants in chronic back pain: a preliminary concentration-controlled trial. J Clin Psychopharmacol 2007, 27:135–142.

    Article  PubMed  CAS  Google Scholar 

  28. Sindrup SH, Grodum E, Gram LF, et al.: Concentration-response relationships in paroxetine treatment of diabetic neuropathy symptoms: a patient-blind dose-escalation study. Ther Drug Monit 1991, 13:408–414.

    Article  PubMed  CAS  Google Scholar 

  29. Backonja M, Glanzman RL: Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials. Clin Ther 2003, 25:81–104.

    Article  PubMed  CAS  Google Scholar 

  30. Dworkin RH, Corbin AE, Young JP Jr, et al.: Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 2003, 60:1274–1283.

    PubMed  CAS  Google Scholar 

  31. Lesser H, Sharma U, LaMoreaux L, et al.: Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. Neurology 2004, 63:2104–2110.

    PubMed  CAS  Google Scholar 

  32. Richter RW, Portenoy R, Sharma U, et al.: Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. J Pain 2005, 6:253–260.

    Article  PubMed  CAS  Google Scholar 

  33. Rice ASC, Maton S, Postherpetic Neuralgia Study Group: Gabapentin in postherpetic neuralgia: a randomized, double blind, placebo-controlled study. Pain 2001, 94:215–224.

    Article  PubMed  CAS  Google Scholar 

  34. Dworkin RH, O’Conner AB, Backonja M, et al.: Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 2007, 132:237–251.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. VA San Diego Healthcare System, 3350 La Jolla Village Drive, 116A, San Diego, CA, 92161, USA

    J. Hampton Atkinson

Authors
  1. J. Hampton Atkinson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shetal M. Patel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jonathan M. Meyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mark A. Slater
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sidney Zisook
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Edmund Capparelli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. Hampton Atkinson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hampton Atkinson, J., Patel, S.M., Meyer, J.M. et al. Is there a therapeutic window with some antidepressants for analgesic response?. Current Science Inc 13, 93–99 (2009). https://doi.org/10.1007/s11916-009-0018-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11916-009-0018-9

Keywords

Search

Navigation